Physician profile
Anna Wilder
NPI 1013514892
$8,430.89
in general payments reported to CMS, 2019-2025
63 companies · $1,718 in 2025
The $1,718 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,348 · 2022: $1,497 · 2023: $1,406 · 2024: $2,462 · 2025: $1,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,585.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,230.08 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $661.23 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $656.44 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $603.15 | 2021-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $564.26 | 2021-2025 | |
| Abbvie INC. | $547.96 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $528.29 | 2021-2025 | Jardiance, Stiolto Respimat |
| Abbott Laboratories | $490.96 | 2021-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $232.72 | 2021-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $205.64 | 2021-2025 | Xifaxan |
| Gilead Sciences, INC. | $189.09 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $160.93 | 2022-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $152.50 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $134.50 | 2021-2025 | Ajovy |
| Biohaven Pharmaceutical Holding Company LTD. | $124.30 | 2022 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $114.82 | 2023-2025 | Accrufer |
| Janssen Pharmaceuticals, INC | $113.30 | 2022-2024 | Xarelto |
| Dexcom, INC. | $96.72 | 2023-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $95.42 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $88.08 | 2021-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Idorsia Pharmaceuticals US INC | $86.12 | 2023-2024 | Tryvio, Quviviq |
| Xeris Pharmaceuticals, INC. | $82.46 | 2025 | Gvoke Hypopen, Recorlev |
| Ardelyx, INC. | $71.92 | 2024-2025 | Ibsrela |
| Amarin Pharma, INC. | $64.85 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $59.86 | 2024-2025 | Caplyta |
| Lundbeck LLC | $58.93 | 2023-2024 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $56.08 | 2021-2024 | Zoryve |
| Ironwood Pharmaceuticals, INC | $54.92 | 2021 | |
| Corium, LLC | $52.30 | 2023 | Azstarys |
| Dynavax Technologies Corporation | $50.46 | 2024 | Heplisav-B |
| Exact Sciences Corporation | $48.80 | 2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $44.59 | 2021 | |
| Supernus Pharmaceuticals, INC. | $43.77 | 2024 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $41.73 | 2022-2023 | |
| Currax Pharmaceuticals LLC | $41.24 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $37.95 | 2021 | |
| Inspire Medical Systems, INC. | $37.92 | 2025 | Inspire |
| Viatris Specialty LLC | $36.03 | 2025 | Yupelri |
| Astellas Pharma US INC | $30.98 | 2024-2025 | Veozah |
| Edwards Lifesciences Corporation | $30.00 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Nestle Healthcare Nutrition INC. | $27.95 | 2021 | |
| Mylan Specialty L.P. | $25.26 | 2023 | Yupelri |
| Ars Pharmaceuticals Operations, INC. | $22.92 | 2025 | Neffy |
| Biogen, INC. | $22.80 | 2024 | Leqembi |
| Boston Scientific Corporation | $22.22 | 2023 | Wavewriter Alpha Prime 16 |
| Atricure, INC. | $21.86 | 2022 | |
| Esperion Therapeutics, INC. | $20.90 | 2025 | Nexletol |
| Philips North America LLC | $18.62 | 2024 | (Ck6) Holter |
| Tolmar, INC. | $18.24 | 2025 | Jatenzo |
| Seqirus USA INC | $18.15 | 2022 | |
| Viiv Healthcare Company | $17.42 | 2022 | |
| Endo Pharmaceuticals INC. | $16.88 | 2023 | Aveed, Xiaflex |
| Abiomed | $16.18 | 2024 | Impella |
| Axsome Therapeutics, INC. | $16.13 | 2024 | Sunosi |
| Novartis Pharmaceuticals Corporation | $16.12 | 2023 | |
| Amneal Pharmaceuticals LLC | $14.81 | 2024 | Unithroid |
| Baxter Healthcare | $14.75 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Vivus LLC | $14.60 | 2022 | |
| Bausch Health US, LLC | $14.27 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $13.92 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.90 | 2021 | |
| Almatica Pharma LLC | $13.54 | 2022 | |
| Tms Neurohealth Centers INC. | $8.15 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Wilder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.